ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Articles tagged "Immunosuppression"

  • 2018 American Transplant Congress

    Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial

    C. Leibler,1 F. Canoui,2 M. Matignon,1 E. Rondeau,3 A. Zarour,2 A. Durrbach,4 S. Malard,5 P. Grimbert.1

    1Nephrology Transplantation, APHP Henri Mondor, Creteil, France; 2Public Health, APHP Henri Mondor, Creteil, France; 3Nephrology Transplantation, APHP Tenon, Paris, France; 4Nephrology Transplantation, APHP Bicêtre, Le Kremlin Bicêtre, France; 5Histocompatibility, APHP Saint Louis, Paris, France.

    IntroductionAntibody-mediated rejection (ABMR) is currently a critical question in kidney transplant recipient with immunological risk factors such as pre transplant donor-specific anti HLA antibodies (DSA).…
  • 2018 American Transplant Congress

    Identification of Anti-Inflammatory and Pro-Inflammatory Gut Microbiota That Determine Graft Survival

    Y. Xiong, C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.

    UMB, MD.

    Introduction: The gut microbiota induce and train the host immune system. Whether microbiota from contrasting environments of colitic or pregnant mice are pro- or anti-inflammatory…
  • 2018 American Transplant Congress

    Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

    M. J. Barten,1 S. W. Hirt,1 J. Garbade,1 C. Bara,1 A. Doesch,1 C. Knosalla,1 C. Grinninger,1 J. Stypmann,1 C. Sieder,2 M. Junge,2 U. Schulz.1

    1Mandela Study Group, Germany; 2Novartis, Pharma, Germany.

    Purpose: The MANDELA study (NCT00862979) was designed to assess the benefit on renal function of either CNI-free or CNI-minimized EVR-based regimen after early conversion of…
  • 2018 American Transplant Congress

    Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

    J. Donnelly,1 P. MacLennan,1 R. Mannon,1 R. Saran,2 J. Baddley,1 H. Wang,3 G. McGwin, Jr.,1 P. Muntner.1

    1University of Alabama at Birmingham, Birmingham, AL; 2University of Michigan, Ann Arbor, MI; 3University of Texas Health Science Center, Houston, TX.

    OBJECTIVE: The association between post-transplant tacrolimus exposure and sepsis risk is currently unknown. We examined the associations of tacrolimus adherence and discontinuation with sepsis risk…
  • 2018 American Transplant Congress

    Human CD8+CD28– Ts Cells Expanded by Common Gamma Chain (γc) Cytokines Keep Steady Allospecific Suppressive Capacity In Vivo

    G. Liu,1 F. Feng,1 P. Zhu,1 J. Liu,2 Y. Liu,1 Y. Yu.2

    1Department of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China; 2Department of Urology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

    Background: CD8+CD28- T suppressor (Ts) cells were recently reported to play a critical role in transplant tolerance, harnessing the potential for clinical use in transplantation.…
  • 2018 American Transplant Congress

    Risk of Bacteremia According to Transplant Induction Immunosuppression Regimen

    E. Misch, S. Kelley, G. Leverson, B. Astor, D. Kaufman.

    University of Wisconsin School of Medicine and Public Health, Madison.

    Background: Transplant immune suppression is designed to suppress the adaptive immune response and ensure graft survival, but may have unintended effects on innate immunity. Few…
  • 2018 American Transplant Congress

    Absence of Rejection in a Facial Allograft Recipient with a Postive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20+ Monoclonal Antibody

    B. Gelb,1 J. Diaz-Siso,2 N. Plana,2 A. Jacoby,2 W. Rifkin,2 K. Khouri,2 D. Ceradini,2 E. Rodriguez.2

    1Transplant Institute, NYU Langone Health, New York, NY; 2Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY.

    OBJECTIVE: Vascularized composite allograft (VCA) transplantation has become a feasible reconstructive option for patients with severe facial disfigurement. Short term patient and graft survival have…
  • 2018 American Transplant Congress

    The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

    A. Khalil,1 A. Chhabra,1 A. Merchak,1 L. Kahn,1 J. Leventhal,2 S. Ildstad.1

    1Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; 2Northwestern University, Chicago, IL.

    Background: Thirty-six subjects have been enrolled in a phase II clinical trial aimed to induce tolerance through chimerism. Each subject received FCRx (mPBMC enriched in…
  • 2018 American Transplant Congress

    Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients

    K. Tornatore,1,4 K. Attwood,2 D. Brazeau,3 S. Chang,4 R. Venuto.4

    1Pharmacy, School of Pharmacy, University at Buffalo(UB), Buffalo; 2Biostatistics, RPCI, Buffalo; 3Pharmaceutical Sciences, University of New England, Portland; 4Nephrology, UB School of Medicine, Buffalo.

    Background: African American(AA) renal transplant recipients(RTR) require larger tacrolimus(TAC) doses to achieve similar troughs to Caucasians which may be due to CYP3A5 polymorphisms. TAC pharmacokinetics…
  • 2018 American Transplant Congress

    The Impact of Conversion from Immediate Release Twice-Daily Tacrolimus (Prograf®) to Once-Daily Extended Release Tacrolimus (Envarsus®) in Liver Transplant Recipients

    M. Del Gaudio,1 M. Cescon,1 M. Ravaioli,1 V. Bertuzzo,1 C. Zanfi,1 M. Serenari,1 L. Maroni,1 C. Morelli,2 A. Pinna.1

    1Organ Insufficiency and Transplantation, S.Orsola Hospital General Surgery and Transplantation Unit Prof. A.D. Pinna, Bologna, Italy; 2Organ Insufficiency and Transplantation, S. Orsola Hospital Organ Insufficiency and Internal Medicine Morelli, Bologna, Italy.

    The safety and efficacy of substitution with a novel once-daily extended-release tacrolimus (LCPT;Envarsus®)to immediate-release tacrolimus (IR-Tac, Prograf®) twice daily in liver transplant patients have not…
  • 1
  • 2
  • 3
  • …
  • 74
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

This site uses cookies: Find out more.